February is National Heart Month—a perfect time to highlight the important role lung health plays in heart health! Did you know that frequent #COPD flare-ups more than triple the risk of sudden cardiac death compared to people with COPD who don’t have frequent flare-ups? The connection is clear: improving lung health is essential to improving outcomes for people with heart disease. At #Nuvaira, we are committed to improving lung health with durable solutions that make patients’ lives easier. Let’s work together to drive awareness, improve treatment, and make a lasting impact. #HeartHealth #LungHealth #BetterOutcomes
Nuvaira, Inc.
医疗设备
Maple Grove,Minnesota 5,479 位关注者
Our dNerva® Lung Denervation System is an investigative COPD therapy that aims to preserve patient lung health.
关于我们
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide. The dNerva® Lung Denervation System is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA.
- 网站
-
http://www.nuvaira.com
Nuvaira, Inc.的外部链接
- 所属行业
- 医疗设备
- 规模
- 51-200 人
- 总部
- Maple Grove,Minnesota
- 类型
- 私人持股
- 创立
- 2008
- 领域
- COPD、Pulmonology、lung denervation、obstructive lung disease、Interventional Pulmonology、chronic obstructive lung disease、Bronchoscopy、Bronchology和medical devices
地点
-
6500 Wedgewood Rd N
US,Minnesota,Maple Grove,55311
Nuvaira, Inc.员工
动态
-
Happy National Inventors’ Day! Today, we celebrate the creativity and passion of those who dream big and turn challenges into breakthroughs. At Nuvaira, innovation is at the heart of everything we do. By developing cutting-edge solutions for COPD, we aim to transform lives and empower patients to breathe easier and live better. We’re proud of inventors past and present who continue to inspire us to push boundaries and reimagine what’s possible in healthcare. Here’s to the thinkers, creators, and problem-solvers shaping a healthier future! #NationalInventorsDay #InnovationInHealthcare #COPDInnovation #HealthcareHeroes #TransformingLives #Nuvaira
-
-
Today, we honor Dr. Martin Luther King Jr., whose visionary leadership continues to inspire progress, equality, and justice. Let’s reflect on how we can each contribute to a more just and inclusive world—through kindness, innovation, or collaboration, every effort makes a difference. #Nuvaira #MLKDay #Inspiration #EqualityForAll
-
-
As 2024 comes to a close, we want to express our heartfelt gratitude to our patients, partners, and the entire healthcare community. Your dedication and trust inspire us to continue innovating solutions that improve the lives of those living with COPD. As we head into 2025, we’re excited to keep working on improving respiratory care and making a positive difference in patients’ lives. #HappyHolidays #ThankYou #Nuvaira #COPD
-
-
Yesterday, the Nuvaira team had the privilege of volunteering at Feed My Starving Children. Together, we helped pack over 14,000 meals to support children in need. It was a rewarding experience, and we're grateful to contribute to such an impactful cause! #FMSC #Teamwork #Nuvaira #Volunteer
-
-
CONGRATULATIONS to Dr. Criner and the Interventional Pulmonary team at Temple Health – Temple University Health System in Philadelphia, PA for successfully completing two additional crossover Targeted Lung Denervation (#TLD) procedures today! TLD is a bronchoscopic, investigational treatment using the #dnerva Lung Denervation System designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce #COPD exacerbations. #bronchoscopy #pulmonology #interventionalpulmonology #medicaldevices #nuvaira
-
-
CONGRATULATIONS to Prof. Shah and the Interventional Pulmonary team at the Royal Brompton and Harefield hospitals in London, UK for successfully completing yet another crossover Targeted Lung Denervation (#TLD) procedure yesterday! TLD is a bronchoscopic, investigational treatment using the #dnerva Lung Denervation System designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce #COPD exacerbations. #bronchoscopy #pulmonology #interventionalpulmonology #medicaldevices #nuvaira
-
-
CONGRATULATIONS to Prof. Slebos and the Interventional Pulmonary team at UMCG in Groningen, Netherlands for performing another crossover Targeted Lung Denervation (#TLD) procedure today! TLD is a bronchoscopic, investigational treatment using the #dnerva Lung Denervation System designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce #COPD exacerbations. #bronchoscopy #pulmonology #interventionalpulmonology #medicaldevices #nuvaira
-
-
Happy Independence Day from all of us at Nuvaira. Whether you’re enjoying a backyard barbecue, watching fireworks, or spending time with loved ones, we wish you a safe and joyful holiday. #FourthOfJuly #IndependenceDay #Nuvaira
-
-
CONGRATULATIONS to Dr. Bhatt and the Interventional Pulmonary team at the University of Alabama in Birmingham, AL for performing another crossover Targeted Lung Denervation (#TLD) procedure today! TLD is a bronchoscopic, investigational treatment using the #dnerva Lung Denervation System designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce #COPD exacerbations. The dNerva Lung Denervation System is an investigational device in the United States. #bronchoscopy #pulmonology #interventionalpulmonology #medicaldevices
-